Please assess the completion status of the following clinical trial:

Trial Title: PECS-2 for Breast Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria: Unilateral surgery on the breast because of suspected malign disease.~Exclusion Criteria:~Bilateral surgery~Metastases other than in the axilla~Body Mass Index (BMI) \> 35~Not able to communicate in Swedish~Dementia~American Society of Anesthesiology (ASA) 4 or 5~Chronic pain treatment (use of opiates or medicine for neuropathic pain \> 7 days the last month)~Known allergy to Morphine or Ropivacaine~Congestive Heart Failure, New York Heart Association (NYHA) IIIB or worse~Chronic renal failure (S-creatinine increased)~Immunosuppression (more than 10 mg daily of Prednisolone or stronger medication)~No axillary exploration planned

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GA with RA (Type: ACTIVE_COMPARATOR): Regional Anesthesia and General Anesthesia.
- GA without RA (Type: ACTIVE_COMPARATOR): Only General Anesthesia (without a supplemental Regional Anesthesia).

Based on this trial design, predict the completion outcome and termination type (if applicable).